Salix

Why Salix Pharmaceuticals' Good Data Wasn't Great
Motley Fool
Wed, 07/2/14 - 09:57 am
Salix
Xifaxan
Salix Pharma Hits A New High On Bullish Clinical-Trial Data
Yahoo/Investors Business Daily
Wed, 07/2/14 - 12:00 am
Salix
clinical trials
Xifaxan
IBS-d
U.S. FDA advisors set to review opioid constipation drugs
Yahoo/Reuters
Mon, 06/9/14 - 11:04 am
FDA
opioid-induced constipation
Salix
Relistor
Cubist Pharmaceuticals
Entereg
AstraZeneca
Nektar
Naloxegol
Top 10 Pharma M&A deals of 2013
Fierce Pharma
Thu, 04/17/14 - 08:29 am
M&A
Amgen
ONYX Pharmaceuticals
Bausch & Lomb
Valeant Pharmaceuticals
Elan
Perrigo
Actavis
Warner Chilcott
Bristol-Myers Squibb
AstraZeneca
Pearl Therapeutics
Agila
Mylan
Salix
Santarus
Bayer
Algeta
Shire
ViroPharma
Zacks Industry Outlook Highlights: Eli Lilly, AstraZeneca, Shire, Salix and Cubist Pharmaceuticals
Yahoo/Zacks.com
Thu, 03/27/14 - 09:47 am
Eli Lilly
Shire
Salix
AstraZeneca
Cubist Pharmaceuticals
M&A
Furiex Diarrhea Drug May Lure Takeover by Salix: Real M&A
Bloomberg
Wed, 03/19/14 - 03:55 pm
Salix
Furiex Pharmaceuticals
M&A
eluxadoline
irritable bowel syndrome
Ten Top Biotech Merger and Partnership Candidates
Wall St 24/7
Fri, 03/14/14 - 10:53 am
M&A
biotech
Alkermes
Akorn
Auxilium
Cubist Pharmaceuticals
Hospira
Jazz Pharmaceuticals
Medivation
NPS Pharmaceuticals
Salix
United Therapeutics
Evoke Pharma Moves Full Speed Ahead
Seeking Alpha
Mon, 01/27/14 - 09:17 am
Evoke Pharma
diabetes
metoclopramide
EVK-001
GSK
Theravance
Salix
Salix Pharma Completes Acquistion of Santarus
Yahoo/Zacks.com
Sat, 01/4/14 - 04:15 pm
M&A
Salix
Santarus
Santarus, Inc. and Salix Pharmaceuticals, Ltd. Merger May Not Be in Santarus, Inc. Shareholders' Best Interests
Yahoo/PR NewsWire
Sat, 11/9/13 - 12:21 pm
Santarus
Salix
M&A
Salix bolsters gastro drug line-up with $2.6 billion Santarus buy
Yahoo/Reuters
Fri, 11/8/13 - 08:23 am
Salix
Santarus
M&A
Salix Pharmaceuticals Announces Quarterly Earnings, Beats Expectations By $0.06 EPS
Watch List News
Sat, 08/10/13 - 01:27 pm
Salix
earnings
Salix Pharma Stock Falls On Earnings, Guidance Miss
Investors.com
Fri, 08/9/13 - 01:04 pm
earnings
Salix
Salix, Progenics shares rise after FDA panel says it will review constipation drug Relistor
Yahoo/AP
Tue, 06/11/13 - 05:00 pm
FDA
Salix
Progenics
advisory panels
constipation
Relistor
Strong Relistor Sales Drive New Rally In Progenics
Seeking Alpha
Tue, 03/19/13 - 11:13 am
Progenics
Relistor
Salix
opioid-induced bowel dysfunction
Salix Pharmaceuticals Price Target Raised to $53.00 at Brean Murray (SLXP)
Jags Report
Sun, 03/3/13 - 11:26 am
Salix
Salix scores FDA approval for HIV-related diarrhea drug Fulyzaq
FierceMedicalDevice
Mon, 12/31/12 - 04:56 pm
Salix
FDA
HIV
This Week in Biotech: Part 2
Motley Fool
Sat, 11/17/12 - 01:49 pm
Clovis Oncology
Eli Lilly
Celgene
Nektar
AstraZeneca
Salix
Progenics Pharmaceuticals
Dynavax Technologies
Tranzyme
Gilead, Salix, Peregrine, Navidea Approach Key Dates In September
Minyanville
Tue, 09/4/12 - 12:27 pm
Gilead
Salix
Peregrine Pharmaceuticals
Navidea Biopharmaceuticals
Crofelemer
tobramycin
Lymphoseek
bavituximab
Truvada
Eylea
Regeneron
lixivaptan
Cornerstone Therapeutics
3 Highly Liquid Drugmakers Undervalued By EPS Trends
Seeking Alpha
Sat, 08/25/12 - 12:50 pm
Salix
Cubist Pharmaceuticals
United Therapeutics

Pages